Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beki Therapeutics is a biotechnology company headquartered in South San Francisco, California, focused on the development of novel therapies for neurodegenerative diseases. The company was founded by Dr. Arnon Rosenthal, a pioneer in the field of neuro-immunology and the co-founder of Alector and Rinat Neuroscience. Beki Therapeutics leverages a deep understanding of the brain's immune system to identify and target pathways that contribute to neuroinflammation and neuronal loss. Its primary mission is to create transformative treatments for conditions such as Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis (ALS). Currently operating in an early stage, the company utilizes advanced antibody engineering to develop its pipeline of therapeutic candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beki Bio.